Alcohol and Drug Treatment and Rehabilitation Program

2005
ISBN: 00-662-69404-X
Cat. No.: H128-1/05-443-10

Help on accessing alternative formats, such as PDF, MP3 and WAV files, can be obtained in the alternate format help section.

(749K)

Canada's Drug Strategy is the federal response to the harmful use of substances. These include illegal drugs, alcohol, pharmaceuticals, inhalants and solvents. The Strategy takes a balanced approach to reducing both the demand for, and the supply of, drugs and substances. It contributes to a healthier, safer Canada through prevention, treatment, enforcement, and harm reduction initiatives.

Reducing harm through treatment and rehabilitation

Helping to ensure that Canadians with drug and alcohol problems have access to treatment and rehabilitation programs is an important part of Canada's Drug Strategy's activities to reduce harm to individuals, families and communities. The delivery of treatment is primarily the responsibility of provincial and territorial governments; however, the Government of Canada contributes $14 million annually toward the cost of treatment and rehabilitation programs through a series of bilateral contribution agreements with participating provinces and territories.

These funds are provided through Canada's Drug Strategy's Alcohol and Drug Treatment and Rehabilitation Program (ADTR). While primarily for treatment programs and services for women and young Canadians, programs aimed at other high-risk groups that may require specialized services are also eligible for support through ADTR. By making a financial contribution to the operation of these various treatment programs and services, the ADTR Program provides women, youth and members of other high-risk groups with greater access to treatment and rehabilitation, and also increases the participation of these groups in treatment programs.

A range of services and programs are cost-shared through the ADTR Program, including detoxification programs, outreach, early identification and intervention, therapeutic intervention, assessment and referral, continuing care and clinical follow-up, among others.

The Program also supports evaluation of treatment and rehabilitation programs, as well as research activities in collaboration with provincial and territorial governments. This component of the Program is aimed at creating knowledge on treatment and rehabilitation through the development of best practices, and at distributing this information to a wide range of stakeholders.

Among other advancements, the research supported through the ADTR Program has formed the basis for a series of treatment and rehabilitation Best Practices booklets published by Health Canada's Office of Demand Reduction. The first in the series was published in 1999, and topics have included women, youth, methadone and impaired drivers.

The publications have generated a positive response from service providers, program planners and other governments in Canada and other countries.

To learn more about Canada's Drug Strategy, please visit www.healthcanada.gc.ca/cds

Find out what governments, non-governmental organizations, and other partners are doing –National Framework for Action – Visit www.healthcanada.gc.ca/cds-nfa